(WASHINGTON, D.C.) - May 7, 2002 - Biotechnology Industry Organization (BIO) President Carl B. Feldbaum will address the key political and regulatory issues that affect the biotechnology industry in a keynote luncheon address at The Wall Street Transcript’s Second Annual Biotechnology Industry Conference on May 9 in New York.
Feldbaum joins other industry executives and financial professionals at the meeting, which will be held at the Princeton Club, 15 West 43rd Street, New York, N.Y. Conference attendees will receive a comprehensive assessment of the state of the industry with specific emphasis on transgenic technology, vaccine technology development, bioterrorism research, and new financing and business trends. For more information or to register, contact Joanna Schmitke at (212) 952-7400, ext. 136.
BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.
# # #